Inversion | No. Positive / No. Screened (% Positive) | ||
---|---|---|---|
Kela | Sidarebougou | Total | |
32 / 215 (14.9%) | 27 / 179 (15.1%) | 59 / 335 (15.0%) | |
2La Inversion | |||
Standard | 0 / 0 (0%) | 0 / 0 (0%) | 0 / 0 (0%) |
Heterozygous | 1 / 2 (50%) | 1 / 14 (7.1%) | 2/ 16 (12.5%) |
Inversion | 31 / 213 (14.6% | 26 / 165 (15.8%) | 57 / 378 (15.1%) |
Statistic | NAa | NA | X2 = 0.080; df = 1; P = 0.777 |
2Rb Inversion | |||
Standard | 8 / 83 (9.6%) | 1 / 9 (11.1%) | 9 / 92 (9.8%) |
Heterozygous | 14 / 90 (15.6%) | 7 / 47 (14.9%) | 21 / 137 (15.3%) |
Inversion | 10 / 42 (23.8%) | 19 / 123 (15.4%) | 29 / 165 (17.6%) |
Statistic | X2 = 4.48; df = 2; P = 0.107 | X2 = 0.125; df = 2; P = 0.939 | X2 = 2.84; df = 2; P = 0.242 |
2Rc Inversion | |||
Standard | 11 / 46 (23.9%) | 19 / 139 (13.7%) | 30 / 185 (16.2%) |
Heterozygous | 9 / 46 (19.6%) | 5 / 30 (16.7%) | 14 / 76 (18.4%) |
Inversion | 12 / 123 (9.8%) | 3 / 10 (30.0%) | 15 / 133 (11.3%) |
Statistic | X2 = 6.31; df = 2; P = 0.043 | X2 = 2.01; df = 2; P = 0.366 | X2 = 2.36; df = 2; P = 0.307 |
2Rd Inversion | |||
Standard | 31 / 210 (14.8%) | 24 / 166 (14.5%) | 55 / 376 (14.6%) |
Heterozygous | 1 / 5 (20.0%) | 3 / 12 (25.0%) | 4 / 17 (23.5%) |
Inversion | 0 / 0 (0%) | 0 / 1 (0.0%) | 0 / 1 (0.0%) |
Statistic | NA | X2 = 0.967; df = 1; P = 0.326 | X2 = 1.01; df = 1; P = 0.315 |
2Rj Inversion | |||
Standard | 20 / 93(21.5%) | 27 / 176 (15.3%) | 47 / 269 (17.5%) |
Heterozygous | 0 / 0 (0.0%) | 0 / 1 (0%) | 0 / 1 (0.0%) |
Inversion | 12 / 122 (9.8%) | 0 / 2 (0%) | 12 / 124 (9.7%) |
Statistic | X2 = 5.67; df = 1; P = 0.017 | NA | X2 = 4.04; df = 1; P = 0.044 |
2Ru Inversion | |||
Standard | 9 / 40 (22.5%) | 24 / 153 (15.7%) | 33 / 193 (17.1%) |
Heterozygous | 12 / 52 (23.1%) | 3 / 24 (12.5%) | 15 / 76 (19.7%) |
Inversion | 11 / 123 (8.9%) | 0 / 2 (0%) | 11 / 125 (8.8%) |
Statistic | X2 = 8.01; df = 2; P = 0.018 | X2 = 0.163; df = 1; P = 0.686 | X2 = 5.78; df = 2; P = 0.056 |